Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition. Tonix Pharmaceuticals Holding Corp. (the “Company”) is disclosing selected preliminary operating results for the
Other Events. The information included in Item 2.02 is incorporated herein by reference. SIGNATURE Pursuant to the requirement of the Securities Exchange Act of